Moderna Inc (MRNA)

Milan
Currency in EUR
22.75
-0.32(-1.39%)
Closed·
MRNA Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
MRNA is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
22.7424.04
52 wk Range
20.67157.28
Key Statistics
Edit
Prev. Close
23.07
Open
23.5
Day's Range
22.74-24.04
52 wk Range
20.67-157.28
Volume
6.92K
Average Vol. (3m)
9.92K
1-Year Change
-84.11%
Book Value / Share
24.06
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
MRNA Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
6 analysts have revised their earnings upwards for the upcoming period
Show more

Moderna Inc Company Profile

Moderna, Inc., a biotechnology company, provides messenger RNA medicines in the United States, Europe, and internationally. The company’s respiratory vaccines include spikevax, mRESVIA, COVID, RSV, seasonal influenza, combination, and pandemic influenza vaccine; latent vaccines comprise cytomegalovirus, epstein-barr virus, herpes simplex virus, varicella zoster virus, and human immunodeficiency virus vaccines; enteric viruses include norovirus; public health vaccines consist of Zika, Nipah, and Mpox vaccines; and bacterial diseases vaccines, such as lyme vaccines. It also provides oncology therapeutics, such as individualized neoantigen and checkpoint adaptive immune modulation therapy; and rare disease products, including propionic and methylmalonic acidemia, glycogen storage disease type 1a, ornithine transcarbamylase deficiency, phenylketonuria, crigler-najjar syndrome type 1, and cystic fibrosis. It has strategic alliances and collaborations with AstraZeneca; Merck & Co., Inc; Vertex Pharmaceuticals Incorporated; Vertex Pharmaceuticals (Europe) Limited; Generation Bio Co.; immatics N.V.; Life Edit Therapeutics; Carisma Therapeutics, Inc.; CytomX Therapeutics; Defense Advanced Research Projects Agency; Biomedical Advanced Research and Development Authority; Institute for Life Changing Medicines; The Bill & Melinda Gates Foundation; and OpenAI. The company was formerly known as Moderna Therapeutics, Inc. and changed its name to Moderna, Inc. in August 2018. Moderna, Inc. was founded in 2010 and is headquartered in Cambridge, Massachusetts.

Employees
5800
Market
Italy

Compare MRNA to Peers and Sector

Metrics to compare
MRNA
Peers
Sector
Relationship
P/E Ratio
−3.1x4.4x−0.4x
PEG Ratio
−0.070.000.00
Price / Book
1.0x1.1x2.6x
Price / LTM Sales
3.3x2.7x2.9x
Upside (Analyst Target)
-152.2%51.7%
Fair Value Upside
Unlock16.3%9.5%Unlock

Earnings

Latest Release
May 01, 2025
EPS / Forecast
-2.52 / --
Revenue / Forecast
108.00M / --
EPS Revisions
Last 90 days

People Also Watch

503.46
BRKb
-0.02%
228.72
AVGO
-0.79%
295.57
UNH
-0.37%
145.38
QCOM
-1.35%
131.29
NVDA
-1.16%

FAQ

What Is the Moderna Inc (MRNA) Stock Price Today?

The Moderna Inc stock price today is 22.75

What Stock Exchange Does Moderna Inc Trade On?

Moderna Inc is listed and trades on the Milan Stock Exchange stock exchange.

What Is the Stock Symbol for Moderna Inc?

The stock symbol for Moderna Inc is "MRNA."

What Is the Moderna Inc Market Cap?

As of today, Moderna Inc market cap is 8.95B.

What Is Moderna Inc's Earnings Per Share (TTM)?

The Moderna Inc EPS (TTM) is -8.72.

From a Technical Analysis Perspective, Is MRNA a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has Moderna Inc Stock Split?

Moderna Inc has split 0 times.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.